Skip to content
Company Analysis

Amarin Corporation plc AMRN

A comprehensive view of key metrics, scores, and financial health for Amarin Corporation plc

Overview of Amarin Corporation plc

AMRN NCM
Healthcare Drug Manufacturers - General Framework: Pharma / Mature Biotech Micro Cap
Amarin Corporation plc (AMRN), is a Micro Cap company, in the Drug Manufacturers - General industry, last closed at $12.13, about 37.9% undervalued vs fair value, -22.6% 1Y return, ranked 930/1145 in sector.
Metrics Rev Growth -6.6% ROE -8.2% Gross Margin 56.6%
USD 12.13
0.17%
(Delayed)
• Vol 90d: 28.2%
52-Week Range
Market Cap
$255.60M
Enterprise Value
$112.04M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 90%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.amarincorp.com
HQ Dublin
Employees 275
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$15
$17
$19
Current: $12.13 +38% vs base

Engine Room Money Flow™

Micro Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$213.6M
-6.5%%
Gross Profit
$120.9M
48.5%%
R&D Expense
$19.8M
-5.1%%
Operating Income (EBIT)
-$36.0M
53.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

R&D Intensity
9.3%
Fair

Lower R&D intensity - may indicate mature portfolio or cost cuts

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
2/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Amarin Corporation plc's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
21
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Strong Liquidity Buffer Liquidity position is strong (score 0.95), providing operational cushion.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 11.1th percentile with high volatility suggests weak pricing power or commoditized products.
  • Below-Peer Operating Efficiency Operating margin at 11.1th percentile indicates below-peer efficiency.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
11
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 85% Coverage
Trade-Off Triangle Visualization A ternary plot showing AMRN's balance between Growth (22.0%), Profitability (30.6%), and Safety (47.5%). Growth 22% Safety 47% Profitability 31%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

28th percentile vs peers
29
Key Signals
EPS Growth YoY 53.2% 53p Rev Growth YoY -6.6% 24p Revenue CAGR 3Y -16.7% 13p
Strengths
  • Cash Flow to Debt Ratio in top 20% of peers (3.31, 86th percentile)
  • Strong liquidity position vs peers
  • Conservative leverage compared to industry peers
Risks

No significant risks identified for this axis.

Profitability

39th percentile vs peers
40
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

61th percentile vs peers
62
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Amarin Corporation plc.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$16.73
- - -
+37.9% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000